Alkermes (ALKS) Net Cash Flow (2010 - 2026)
Alkermes' (ALKS) quarterly Net Cash Flow came in at -$768.2 million in Q1 2026, down 807.0% year-on-year from $108.7 million in Q1 2025, and down 252.63% on a QoQ basis from $503.3 million in Q4 2025.
Alkermes (ALKS) Net Cash Flow (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Net Cash Flow data on file, last reported at -$768.2 million in Q1 2026.
- On a quarterly basis, Net Cash Flow fell 807.0% year-over-year to -$768.2 million in Q1 2026; TTM through Mar 2026 was -$48.3 million, a 130.36% decrease from a year earlier, with the FY2025 full-year figure at $828.6 million, up 598.21% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$768.2 million, down from $503.3 million in the prior quarter.
- Over the last five years, Net Cash Flow for ALKS reached as high as $503.3 million in Q4 2025 and fell as low as -$768.2 million in Q1 2026.
- Historically, Net Cash Flow has averaged $824000.0 across 5 years, with a median of $9.3 million in 2022.
- Across the five-year window, Net Cash Flow soared 1333.9% in 2023 and slumped 807.0% in 2026, its largest moves.
- Year by year, Net Cash Flow stood at $28.5 million in 2022, then sank by 767.14% to -$190.2 million in 2023, then soared by 44.73% to -$105.1 million in 2024, then surged by 578.69% to $503.3 million in 2025, then tumbled by 252.63% to -$768.2 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$768.2 million in Q1 2026, $503.3 million in Q4 2025, and $95.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -768.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -768.22 Mn |
| Mar 31, 2026 | -768.22 Mn |
| Dec 31, 2025 | 503.33 Mn |
| Dec 31, 2025 | 503.33 Mn |
| Sep 30, 2025 | 95.25 Mn |
| Sep 30, 2025 | 95.25 Mn |
| Jun 30, 2025 | 121.39 Mn |
| Jun 30, 2025 | 121.39 Mn |
| Mar 31, 2025 | 108.66 Mn |
| Mar 31, 2025 | 108.66 Mn |
| Dec 31, 2024 | -105.15 Mn |
| Dec 31, 2024 | -105.15 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Jun 30, 2024 | 114.40 Mn |
| Jun 30, 2024 | 114.40 Mn |
| Mar 31, 2024 | -36.72 Mn |
| Mar 31, 2024 | -36.72 Mn |
| Dec 31, 2023 | -190.24 Mn |
| Dec 31, 2023 | -190.24 Mn |